Volitionrx Limited (VNRX) Reports Q1 Loss of $0.12/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. BA
4. STX
5. NXPI
6. SPY
7. NOW
8. GOOGL
9. KIDS
10. GOOG

Go back to Volitionrx Limited (VNRX) Reports Q1 Loss of $0.12/Share

VolitionRx Announces First Quarter 2015 Financial Results and Business Update

May 12, 2015 7:50 AM EDT

NAMUR, Belgium, May 12, 2015 /PRNewswire/ -- VolitionRx Limited (NYSE MKT: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced financial results for the first quarter ended March 31, 2015. 

First Quarter 2015 and Recent Company Highlights:

Completed NYSE MKT listing in conjunction with $10.6 million fully registered offering of common shares, plus an additional $1.5 million received in funding from a Private Placement in March... More